GVHD
Clinical trials for GVHD explained in plain language.
Never miss a new study
Get alerted when new GVHD trials appear
Sign up with your email to follow new studies for GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop transplant rejection in kids with rare blood diseases
Disease control Not yet recruitingThis study tests whether adding the drug vorinostat to standard anti-rejection medicines can safely prevent graft-versus-host disease (GVHD) in children and young adults (ages 1-26) with non-cancerous blood disorders who receive a bone marrow transplant. About 55 participants wil…
Matched conditions: GVHD
Phase: PHASE2 • Sponsor: Sung Won Choi • Aim: Disease control
Last updated May 17, 2026 04:27 UTC
-
Can patients safely stop Anti-Rejection drugs sooner after transplant?
Disease control Not yet recruitingThis study tests whether patients who receive a stem cell transplant for blood cancers can safely stop taking the immune-suppressing drug tacrolimus earlier than usual. The goal is to reduce side effects while still preventing graft-versus-host disease (GVHD), a common complicati…
Matched conditions: GVHD
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 05, 2026 11:56 UTC